ArticleJACC. Case reports2025
Rare Case of STEMI Involving an Anomalous Single Coronary Artery Arising From the Ascending Aorta.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundST-segment elevation myocardial infarction in an anomalous single coronary artery with high take-off is a rare occurrence with very few cases reported to date. CASE SUMMARY: A 42-year-old man with testicular seminoma undergoing chemotherapy presented with an inferior ST-segment elevation myocardial infarction. Coronary angiography revealed a thrombotic lesion of the anomalous single coronary artery. The patient underwent percutaneous intervention with thrombus aspiration, was managed with dual-antiplatelet therapy and anticoagulation, and was followed up in an outpatient setting with a computed tomography angiogram. DISCUSSION: Stenting was deferred, considering the patient's complex coronary anatomy and overall clinical condition. The possible mechanism of the event may be multifactorial but is likely to be precipitated by the recent chemotherapy-associated vascular toxicity. TAKE-HOME MESSAGES: This case highlights the diagnostic and therapeutic challenges of such unusual clinical presentations, highlighting the importance of multimodality evaluation and treatment, which should be individualized to each patient scenario.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.